Benzinga's Top Initiations

By: via Benzinga
Analysts at Leerink Swann initiated coverage on Carbylan Therapeutics Inc (NASDAQ: CBYL) with a Outperform rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.